z-logo
Premium
Pharmacokinetics of N ‐acetylprocainamide in patients profiled with a stable isotope method
Author(s) -
Atkinson Arthur J,
Ruo Tsuen Ih,
Piergies Antoni A,
Breiter Hans C,
Connelly Timothy J,
Sedek Grzegorz S,
Juan David,
Hubler Gary L,
Hsieh AnnMing
Publication year - 1989
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1989.124
Subject(s) - napa , bioavailability , pharmacokinetics , volume of distribution , chemistry , absorption (acoustics) , crossover study , pharmacology , oral administration , renal function , urology , medicine , biochemistry , materials science , pathology , placebo , alternative medicine , composite material
N ‐Acetylprocainamide (NAPA) absorption and disposition were profiled in five patients with ventricular arrhythmias by the simultaneous intravenous administration of NAPA‐ 13 C and oral administration of a 500 mg NAPA hydrochloride tablet. NAPA distribution was modeled with a three compartment mammillary system. The central compartment volume of 14.1 ± 2.6 L (mean ± SD) was similar to expected intravascular space, corrected for NAPA partitioning between erythrocytes and plasma. Other compartment volumes, intercompartmental and nonrenal clearances, and the steady‐state distribution volume of 1.45 ± 0.09 L/kg were similar to normal subject values. The least‐squares estimate of 1.67 for the NAPA renal clearance/creatinine clearance ratio was similar to the value of 1.68 previously reported for functionally anephric patients and showed the expected age‐associated decrease. The oral NAPA dose was 78.0% ± 11.7% absorbed and interindividual variation in NAPA absorption was correlated with fast intercompartmental clearance ( r = 0.89, p = 0.045). Because fast intercompartmental clearance partly reflects splanchnic blood flow, hemodynamic changes may affect NAPA bioavailability, as has been found for procainamide. Clinical Pharmacology and Therapeutics (1989) 46 , 182–189; doi: 10.1038/clpt.1989.124

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom